AAAAAA
Results:
1-20
|
Results: 20
Authors:
Abarca, J
Armstrong, EP
Citation: J. Abarca et Ep. Armstrong, Improving the use of data sources in disease management programs, DIS MANAG H, 9(9), 2001, pp. 459-471
Authors:
Armstrong, EP
Citation: Ep. Armstrong, Analysis of antidepressant use through hierarchical disease analysis - Using a managed care administrative database, DIS MANAG H, 9(5), 2001, pp. 255-267
Authors:
Armstrong, EP
Krueger, K
Langley, PC
Citation: Ep. Armstrong et al., Analysis of asthma-related costs and patterns of resource utilization in amanaged-care population, DIS MANAG H, 9(3), 2001, pp. 161-171
Authors:
Joish, VN
Armstrong, EP
Citation: Vn. Joish et Ep. Armstrong, Which antifungal agent for onychomycosis? A pharmacoeconomic analysis, PHARMACOECO, 19(10), 2001, pp. 983-1002
Authors:
Armstrong, EP
Citation: Ep. Armstrong, Clinical and economic outcomes of an ambulatory urinary tract infection disease management program, AM J M CARE, 7(3), 2001, pp. 269-280
Authors:
Armstrong, EP
Abarca, J
Citation: Ep. Armstrong et J. Abarca, An examination of the relationship between non-depression-related costs and uninterrupted Tx, FORMULARY, 36(6), 2001, pp. 461
Authors:
Armstrong, EP
Khan, ZM
Perry, AS
Perri, LR
Citation: Ep. Armstrong et al., Zanamivir vs Oseltamivir: Which drug is more cost-effective? Authors' reply, FORMULARY, 36(5), 2001, pp. 384
Authors:
Joish, VN
Limcangco, RMT
Armstrong, EP
Citation: Vn. Joish et al., Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program, FORMULARY, 36(2), 2001, pp. 147
Authors:
Armstrong, EP
Patrick, KL
Erstad, BL
Citation: Ep. Armstrong et al., Comparison of preoperative skin preparation products, PHARMACOTHE, 21(3), 2001, pp. 345-350
Authors:
Armstrong, EP
Cherrick, RE
Citation: Ep. Armstrong et Re. Cherrick, Epoetin alfa drug use evaluation using a software system - Lessons learned, DIS MANAG H, 8(5), 2000, pp. 287-295
Authors:
Joish, VN
Armstrong, EP
Citation: Vn. Joish et Ep. Armstrong, Use of decision analysis in modeling the cost-effectiveness of oval vs SC sumatriptan, FORMULARY, 35(6), 2000, pp. 532
Authors:
Motheral, BR
Grizzle, AJ
Armstrong, EP
Cox, E
Fairman, K
Citation: Br. Motheral et al., Role of pharmacoeconomics in drug benefit decision-making: Results of a survey, FORMULARY, 35(5), 2000, pp. 412
Authors:
Armstrong, EP
Abarca, J
Citation: Ep. Armstrong et J. Abarca, Pharmacoeconomic model to evaluate new influenza treatments, FORMULARY, 35(2), 2000, pp. 169
Authors:
Armstrong, EP
Khan, ZM
Perry, AS
Perri, LR
Citation: Ep. Armstrong et al., The cost effectiveness of zanamivir and oseltamivir for influenza treatment, FORMULARY, 35(12), 2000, pp. 979
Authors:
Abarca, J
Armstrong, EP
Citation: J. Abarca et Ep. Armstrong, How to use multiple logistic regression in retrospective database analyses, FORMULARY, 35(10), 2000, pp. 832
Authors:
Armstrong, EP
Chrischilles, EA
Citation: Ep. Armstrong et Ea. Chrischilles, Electronic prescribing and monitoring are needed to improve drug use, ARCH IN MED, 160(18), 2000, pp. 2713-2714
Authors:
Armstrong, EP
Citation: Ep. Armstrong, Critical evaluation of a decision-analytic model of major depression treatment, FORMULARY, 34(8), 1999, pp. 683-687
Authors:
Armstrong, EP
Citation: Ep. Armstrong, Study design - Evaluating low molecular weight heparins within a health system: Issues and strategies, FORMULARY, 34(2), 1999, pp. 144-148
Authors:
Armstrong, EP
Sauer, KA
Downey, MJ
Citation: Ep. Armstrong et al., Phenytoin and fosphenytoin: A model of cost and clinical outcomes, PHARMACOTHE, 19(7), 1999, pp. 844-853
Authors:
Armstrong, EP
Citation: Ep. Armstrong, Disease management: State of the art and future directions, CLIN THER, 21(3), 1999, pp. 593-609
Risultati:
1-20
|